In Q4 2025, Agilent Technologies, Inc. reported impressive results with quarterly revenue of $1.9 billion and net income of $434 million. This represents a 7.08% increase in revenue on a quarter-over-quarter (QoQ) basis and an impressive 9.41% growth year-over-year (YoY). These figures indicate that Agilent is experiencing solid growth, outpacing sector averages of 14.5% for operating margin and 18.75% for net margin.
Agilent's growth is driven by several emerging trends in the chromatography and microarrays markets. The global chromatography market is projected to expand from $10.03 billion in 2025 to $13.69 billion by 2031 at a CAGR of 5.32%. Agilent has capitalized on this growth with its strong Q4 FY2025 results, reporting $1.86 billion in revenue and $1.59 non-GAAP EPS.
However, high capital costs remain a challenge for smaller entities looking to adopt Agilent's technology, limiting their ability to participate in the growing market. Additionally, integration challenges with legacy systems persist, particularly for smaller laboratories and SMEs. Despite these concerns, the emerging trends in the industry suggest that Agilent is well-positioned for continued growth in the future.
Overall, Agilent Technologies, Inc. presents a compelling investment opportunity due to its strong QoQ and YoY growth, solid financial performance, and emerging market opportunities. While there are potential concerns about high capital costs and integration challenges, investors should consider the company's long-term outlook in light of these trends. As such, Agilent remains an attractive investment opportunity for those looking to capitalize on the growing chromatography and microarrays markets.